-
Oberoi Realty
1,751.00 1,440.05(%) -
Canara Bank
106.35 78.58(%) -
SpiceJet
40.84 79.90(%) -
Lodha Developers
1,330.55 1,036.00(%) -
Havells India
1,549.05 1,360.05(%) -
ICICI Bank
1,489.95 1,489.95(%) -
One 97
1,090.00 1,090.00(%) -
Bombay Dyeing
190.85 256.25(%) -
Ola Electric
43.95 157.53(%) -
Dixon Technolog.
16,671.15 19,149.80(%) -
Anthem Bioscienc
765.00 765.00(%) -
Eternal Ltd
303.60 311.60(%) -
Paradeep Phosph.
205.60 205.60(%) -
Pidilite Inds.
2,900.75 2,620.15(%) -
Reliance Industr
1,426.90 1,551.00(%) -
I R F C
136.90 208.95(%) -
Monika Alcobev
289.95 289.95(%) -
St Bk of India
825.00 889.00(%) -
Waaree Energies
3,199.00 3,740.75(%) -
Jayaswal Neco
43.10 55.34(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Sun Pharmaceutical Industries Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Sun Pharma
- BSE Code : 4325.0
- ISIN : INE044A01036
-
Today’s Low
1,671.40 -
Today’s High
1,689.60

-
Open
1,678.50 -
Perv Close
1,678.00 -
52W Low
1,553.05 -
52W High
1,960.35
Key Indicators
-
P/E(TTM)
94.42
-
Mar.Cap (₹Cr.)
403,688.11
-
Div & Yield %
0.95
-
Book Value(₹)
101.44
-
Debt-Equity Ratio
0.27
-
AGM Date
23-Jul-2025
-
EPS
17.82
-
P/E Ratio
94.42
Financials Ratios
-
Debt-Equity Ratio
0.08
-
Mar.Cap (₹Cr.)
403,688.11
-
RONW (%)
16.13
-
ROCE (%)
17.20
Score Board
-
Equity (₹ in Cr.)
239.93
-
BV (₹)
101.40
-
Sales( ₹ in Cr.)
23,003.33
-
NP (in Cr.)
4,275.54
-
NP Var(%)
40.0
-
Div%
1600.0
-
CPS (₹)
23.00
-
EPS (₹)
17.80
-
Traded Value (₹ in Lakhs)
403,712.10
-
52 Week High
1,960.35
-
52 Week Low
1,553.05
-
Price BSE
1683.0
-
Price NSE
1,683.00
-
Market Capital( in Cr.)
403,712.10
-
P/C Ratio
73.20
-
P/E Ratio
94.40
-
Price Vs.BV
17.80
-
21-Jul-2025( 09:05)
Corporate News - Sun P... - <P>Sun Pharmaceutical Industri...
-
15-Jul-2025( 03:41)
Hot Pursuit - Sun P... - <P> The drug is indicated for...
-
15-Jul-2025( 01:05)
Hot Pursuit - Sun P... - <p>Sun Pharmaceutical Industri...
-
14-Jul-2025( 04:53)
Corporate News - Sun P... - <P> Sun Pharmaceutical In...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 23,003.33 | 20,275.17 | 20,812.14 | 15,585.98 | 14,116.05 | 12,531.93 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 23,003.33 | 20,275.17 | 20,812.14 | 15,585.98 | 14,116.05 | 12,531.93 |
Other Income | 623.97 | 553.48 | 329.29 | 1,196.88 | 192.07 | 1,510.92 |
Stock Adjustments | 69.17 | -180.32 | 237.93 | 183.18 | 179.64 | -138.60 |
Total Income | 23,696.47 | 20,648.33 | 21,379.36 | 16,966.04 | 14,487.76 | 13,904.25 |
EXPENDITURE : | ||||||
Raw Materials | 6,050.20 | 5,423.79 | 6,292.09 | 5,833.57 | 5,287.12 | 4,429.12 |
Power and Fuel Cost | 435.72 | 450.42 | 495.21 | 422.33 | 384.16 | 394.74 |
Employee Cost | 2,608.26 | 2,373.95 | 2,156.95 | 2,000.78 | 1,805.98 | 1,702.77 |
Other Manufacturing Expenses | 1,261.72 | 1,195.30 | 1,037.32 | 1,064.32 | 862.12 | 860.05 |
Selling and Administration Expenses | 5,539.89 | 4,754.86 | 4,326.42 | 3,514.05 | 3,309.62 | 1,919.25 |
Miscellaneous Expenses | 638.63 | 615.66 | 3,257.27 | 2,086.08 | 479.24 | 375.75 |
Employee Benefit Expenses | 2,608.26 | 2,373.95 | 2,156.95 | 2,000.78 | 1,805.98 | 1,702.77 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 16,534.42 | 14,813.98 | 17,565.26 | 14,921.13 | 12,128.24 | 9,681.68 |
Operating Profit | 7,162.05 | 5,834.35 | 3,814.10 | 2,044.91 | 2,359.52 | 4,222.57 |
Interest | 893.21 | 784.08 | 472.18 | 388.10 | 267.52 | 408.01 |
Gross Profit | 6,268.84 | 5,050.27 | 3,341.92 | 1,656.81 | 2,092.00 | 3,814.56 |
Depreciation | 1,238.27 | 1,600.62 | 1,600.87 | 1,349.95 | 1,236.43 | 561.56 |
Profit Before Tax | 5,030.57 | 3,449.65 | 1,741.05 | 306.86 | 855.57 | 3,253.00 |
Current Tax | 908.62 | 546.10 | 752.77 | -553.58 | 244.91 | 386.46 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -160.67 | 45.37 | -702.44 | 960.43 | -231.74 | -344.60 |
Reported Net Profit | 4,282.62 | 2,858.18 | 1,690.72 | -99.99 | 842.40 | 3,211.14 |
Extraordinary Items | 7.08 | -193.46 | -1,665.67 | 1,237.51 | -63.64 | 193.27 |
Adjusted Net Profit | 4,275.54 | 3,051.64 | 3,356.39 | -1,337.50 | 906.04 | 3,017.87 |
Adjustment below Net Profit | -11.87 | -19.86 | 7.38 | -14.53 | 2,675.94 | -211.52 |
P & L Balance brought forward | 12,731.04 | 12,790.88 | 13,612.08 | 15,964.55 | 14,005.27 | 12,384.61 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 3,613.97 | 2,898.16 | 2,519.30 | 2,237.95 | 1,559.06 | 1,378.96 |
P & L Balance carried down | 13,387.82 | 12,731.04 | 12,790.88 | 13,612.08 | 15,964.55 | 14,005.27 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 1,600.00 | 1,350.00 | 1,150.00 | 1,000.00 | 750.00 | 400.00 |
Dividend Per Share(Rs) | 16.00 | 13.50 | 11.50 | 10.00 | 7.50 | 4.00 |
Earnings Per Share-Unit Curr | 17.85 | 11.91 | 7.05 | -0.42 | 3.51 | 13.38 |
Earnings Per Share(Adj)-Unit Curr | 17.85 | 11.91 | 7.05 | -0.42 | 3.51 | 13.38 |
Book Value | 101.45 | 98.76 | 98.98 | 102.48 | 112.28 | 101.68 |
Book Value(Adj)-Unit Curr | 101.45 | 98.76 | 98.98 | 102.48 | 112.28 | 101.68 |